
According to Benzinga Pro, during Q4, Avid Bioservices (NASDAQ:CDMO) earned $115.60 million, a 5042.26% increase from the preceding quarter. Avid Bioservices's sales decreased to $31.23 million, a 0.9% change since Q3. In Q3, Avid Bioservices brought in $31.51 million in sales but only earned $2.25 million.